会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF MILNACIPRAN
    • 米非司酮的控制释放药物组合物
    • WO2011016057A3
    • 2011-10-06
    • PCT/IN2010000520
    • 2010-08-04
    • LUPIN LTDKULKARNI SHIRISH KUMARKULKARNI RAJESHJADHAV PANDHARINATHTIWARI ASHISH
    • KULKARNI SHIRISH KUMARKULKARNI RAJESHJADHAV PANDHARINATHTIWARI ASHISH
    • A61K9/20A61K31/165
    • A61K9/2027A61K9/2013A61K9/2054A61K9/2086A61K9/209A61K9/2095A61K31/165
    • A controlled release pharmaceutical composition comprising Milnacipran or pharmaceutically acceptable salts thereof and hydrophobic release controlling agent. The composition releases 90 % of the total amount of Milnacipran or pharmaceutically acceptable salts thereof between 8 to 20 hours when dissolution is carried out in 900 ml 0.1N HCl, USP apparatus Type I (Basket) at 100 rpm for 2 hrs, followed by 900 ml Phosphate buffer pH 6.8 USP apparatus Type I (Basket) at 100 rpm. A process of preparing a controlled release pharmaceutical composition comprises: a) preparing a first layer comprising i) melting hydrophobic release controlling agent and Milnacipran or pharmaceutically acceptable salts thereof in it ii) cooling followed by sieving the melted mass to obtain granules and iii) lubricating the granules; and b) preparing a second layer comprising granules which comprises hydrophobic release controlling agent and optionally Milnacipran or pharmaceutically acceptable salts thereof.
    • 包含米那普仑或其药学上可接受的盐和疏水性释放控制剂的控释药物组合物。 当在900ml 0.1N HCl,USP装置I型(篮)以100rpm进行2小时进行溶解时,该组合物释放总量的90%的米那普仑或其药学上可接受的盐,接着900 ml磷酸盐缓冲液pH 6.8 USP装置I型(篮)在100rpm下。 制备控释药物组合物的方法包括:a)制备第一层,所述第一层包含i)将疏水释放控制剂和米那普仑或其药学上可接受的盐在其中熔融ii)冷却,然后过滤熔融物质以获得颗粒,和iii)润滑 颗粒; 和b)制备包含颗粒的第二层,所述颗粒包含疏水释放控制剂和任选的米那普仑或其药学上可接受的盐。
    • 16. 发明申请
    • ORAL COMPOSITIONS OF CLINDAMYCIN
    • CLINDAMYCIN口服组合物
    • WO2010010568A1
    • 2010-01-28
    • PCT/IN2008/000579
    • 2008-09-10
    • LUPIN LIMITEDWALZADE, KalpanaKULKARNI, RajeshKULKARNI, Shirishkumar
    • WALZADE, KalpanaKULKARNI, RajeshKULKARNI, Shirishkumar
    • A61K9/00
    • A61K9/0095A61K9/1623A61K9/1641A61K9/5026Y02A50/411
    • A taste masked pharmaceutical composition of clindamycin, or a pharmaceutically acceptable salt(s), hydrate(s), solvate(s) and physiologically functional derivative(s) and precursors thereof, which includes all polymorphic forms, whether crystalline or amorphous comprising polyhydric alcohol(s); and one or more other pharmaceutically acceptable excipient(s). A process for preparation of a taste masked pharmaceutical composition of clindamycin or a pharmaceutically acceptable salt(s) thereof the said process comprising the steps of a) dry mixing clindamycin, polyhydric alcohol and other pharmaceutically acceptable excipient(s) to get a dry mixture; b) granulating the dry mixture above with a granulating liquid prepared by mixing the suitable pharmaceutically acceptable excipient(s) with aqueous /non-aqueous fluid to obtain a wet mass; c) drying the wet mass to obtain the discrete particles; d) lubricating the discrete particles obtained with a suitable lubricating agent and/or flavour(s).
    • 克林霉素或其药学上可接受的盐,水合物,溶剂合物和生理功能衍生物及其前体的掩味药物组合物,其包括所有多晶型物,无论是多晶型还是含有多元醇的无定形物质 (一个或多个); 和一种或多种其它药学上可接受的赋形剂。 制备克林霉素或其药学上可接受的盐的掩味药物组合物的方法,所述方法包括以下步骤:a)将克林霉素,多元醇和其它药学上可接受的赋形剂干混以得到干混合物; b)将上述干混合物用通过将合适的药学上可接受的赋形剂与水/非水性流体混合而制备的造粒液体制粒得到湿物质; c)干燥湿物质以获得离散颗粒; d)润滑用合适的润滑剂和/或风味获得的离散颗粒。